FAST NEWS: BlackRock boosts stake in battered WuXi AppTec
The latest: Asset management company BlackRock Inc. purchased 618,000 Hong Kong-listed shares of WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) on March 26, raising its stake in the drug outsourcing services company from…
FAST NEWS: JPMorgan boosts WuXi AppTec stake
The latest: U.S. banking giant JPMorgan purchased 1.57 million Hong Kong-listed shares of WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) for HK$75.33 million ($9.66 million) on Feb. 8, raising its stake in the drug…
Potential U.S. targeting casts shadow over WuXi AppTec family
Proposed U.S. legislation could ban federal agencies and federally funded institutions from buying devices and services from Chinese biotech companies Key Takeaways: WuXi AppTec, which could be banned from doing…
WuXi Bio prescribes share buyback to relieve revenue pain
The pharma services provider has shocked investors with a steep downward revision of its earnings outlook, slashing its full-year revenue growth forecast to just 10% from an initial 30% and…
FAST NEWS: U.S. investment firm boosts WuXi AppTec stake
The latest: The Capital Group, a U.S. asset manager, disclosed it purchase 2.52 million Hong Kong-listed shares of WuXi AppTec Co. Ltd. (2359.HK; 603259.SH) for HK$177 million ($20.8 million), raising…
Wuxi AppTec finds bitter aftertaste in waning demand for Covid drug services
The leading Chinese CXO posted record revenue and strong profits last year, but its growth started to slow in the fourth quarter Key Takeaways: Wuxi AppTec’s chemical business doubled last…
After 2022 Slowdown, WuXi Biologics Gets Growth Medicine From Big New Order
China’s leading provider of outsourced medical services said its profit and revenue rose 48.4% and 30% last year, respectively, marking a significant slowdown from the previous yearKey Takeaways:WuXi Biologics revenue…
Recent Articles
FAST NEWS: BlackRock boosts stake in battered WuXi AppTec
2359.HK
603259.SHG
FAST NEWS: JPMorgan boosts WuXi AppTec stake
2359.HK
603259.SHG
Potential U.S. targeting casts shadow over WuXi AppTec family
2359.HK
603259.SHG
FAST NEWS: U.S. investment firm boosts WuXi AppTec stake
2359.HK
603259.SHG
Wuxi AppTec finds bitter aftertaste in waning demand for Covid drug services
2359.HK
603259.SHG
RELATED ARTICLES
-
WuXi Biologics hatches new baby with ADC drug unit IPO
2269.HK -
Potential U.S. targeting casts shadow over WuXi AppTec family
2359.HK 603259.SHG
-
FAST NEWS: JPMorgan boosts WuXi AppTec stake
2359.HK 603259.SHG
-
FAST NEWS: U.S. investment firm boosts WuXi AppTec stake
2359.HK 603259.SHG
-
WuXi Bio prescribes share buyback to relieve revenue pain
2269.HK
-
FAST NEWS: WuXi Biologics boosts new projects target
2269.HK
- CHINA BULLETIN: Local Governments Crushed by Debt
